Sign in
BDRX Stock Price, Chart, Stats & News
Biodexa Pharmaceuticals Plc
Save
Biodexa Pharmaceuticals Plc (BDRX) does not currently pay a dividend.
481,317
Market cap
–
Current P/E
–
Forward P/E
BDRX chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.61% |
ROA | -42.01% |
ROE | -63.03% |
D/E | 0.04x |
Interest coverage ratio | -65.64x |
BDRX valuation
P/E | – |
P/S | – |
P/B | 0.01x |
P/CF | -0.01x |
P/FCF | -0.04x |
P/OCF | -0.01x |
PEG | 0.00x |
EV multiple | -0.45x |
About
Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Founded in 2000 and headquartered in Cardiff, United Kingdom, the company was formerly known as Midatech Pharma plc until its rebranding in March 2023. Its research and development efforts are focused on addressing significant unmet medical needs, including familial adenomatous polyposis, non-muscle invasive bladder cancer, Type 1 diabetes, and a spectrum of rare or orphan brain cancers.
Similar securities
Based on sector and market capitalization
Report issue